Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹1,773 Cr₹109 Cr₹-357 Cr₹2,621 Cr₹1,270 Cr

What is the latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹1,773 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹1,773 Cr
Mar2025₹109 Cr
Mar2024₹-357 Cr
Mar2023₹2,621 Cr
Mar2022₹1,270 Cr

How is Total Non-Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹1,773 Cr
1,521.43
Mar2025 ₹109 Cr
Positive
Mar2024 ₹-357 Cr
Negative
Mar2023 ₹2,621 Cr
106.48
Mar2022 ₹1,270 Cr -

Compare Total Non-Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,097.3 Cr -4.2% -13.5% 17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-4.2%

-13.5%

17%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses